Extended-Release Torsemide/Spironolactone
螺内酯/托拉塞米
Report date: 2026/01/04 20:00:05
NME
Base Information
Drug NameExtended-Release Torsemide/Spironolactone
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes SpironolactoneTorasemide
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSarfez Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesSarfez Pharmaceuticals Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A